Table 3.
Comparison of vital signs between the modified high-flow nasal cannula oxygen and the conventional oxygen therapy groups
| Characteristic | Group | Pre-5 min (n = 392/396) | The lowest SpO2, the highest respiratory rate, heart rate, and mean arterial pressure (n = 392/396) | Post-5 min (n = 392/396) | Post-10 min (n = 392/396) | Post-2 h (n = 392/396) | Post-6 h (n = 392/396) | Post-24 h (n = 392/396) | pa |
|---|---|---|---|---|---|---|---|---|---|
| SpO2 (%) | MHFNC | 97.4 ± 1.6 | 94.1 ± 3.2 | 95.4 ± 2.3 | 94.7 ± 2.7 | 95.5 ± 1.8 | 95.7 ± 1.8 | 96.0 ± 1.7 | < 0.001 |
| Control | 97.3 ± 1.5 | 90.5 ± 3.8 | 92.1 ± 2.6 | 93.4 ± 2.9 | 95.3 ± 2.1 | 95.7 ± 1.9 | 95.9 ± 1.8 | < 0.001 | |
| pc | 0.268 | < 0.001 | < 0.001 | < 0.001 | 0.348 | 0.869 | 0.493 | 0.003b | |
| Respiratory rate (bpm) | MHFNC | 17 ± 5 | 26 ± 7 | 19 ± 5 | 19 ± 4 | 18 ± 3 | 17 ± 3 | 17 ± 3 | < 0.001 |
| Control | 18 ± 4 | 28 ± 6 | 21 ± 5 | 20 ± 4 | 18 ± 3 | 17 ± 3 | 17 ± 3 | < 0.001 | |
| pc | 0.196 | < 0.001 | < 0.001 | 0.005 | 0.693 | 0.694 | 0.973 | 0.001b | |
| Heart rate (beats/min) | MHFNC | 84 ± 15 | 112 ± 18 | 94 ± 16 | 93 ± 16 | 83 ± 10 | 82 ± 10 | 81 ± 10 | < 0.001 |
| Control | 83 ± 15 | 116 ± 21 | 97 ± 18 | 94 ± 16 | 82 ± 10 | 81 ± 11 | 80 ± 10 | < 0.001 | |
| pc | 0.305 | 0.015 | 0.037 | 0.377 | 0.167 | 0.818 | 0.334 | 0.465b | |
| Mean arterial pressure (mmHg) | MHFNC | 95 ± 13 | 108 ± 15 | 102 ± 14 | 104 ± 17 | 95 ± 10 | 94 ± 10 | 94 ± 9 | < 0.001 |
| Control | 94 ± 12 | 110 ± 18 | 103 ± 16 | 104 ± 16 | 96 ± 10 | 95 ± 10 | 94 ± 10 | < 0.001 | |
| pc | 0.454 | 0.256 | 0.233 | 0.890 | 0.541 | 0.342 | 0.580 | 0.402b |
FiO2 the fraction of inspired oxygen, SpO2 peripheral arterial oxygen saturation
pa for overall comparisons of differences in each group over time
pb for overall comparisons of differences between groups over time
pc for comparisons of differences between groups at each time point